Hereditary angioedema: the clinical picture of excessive contact activation

RS Petersen, LM Fijen, M Levi… - Seminars in thrombosis …, 2022 - thieme-connect.com
Hereditary angioedema is a rare, genetic disorder characterized by painful, debilitating and
potentially life-threatening angioedema attacks in subcutaneous and submucosal tissue …

Discovery and development of plasma kallikrein inhibitors for multiple diseases

Z Xie, Z Li, Y Shao, C Liao - European journal of medicinal chemistry, 2020 - Elsevier
Plasma kallikrein (PKal) belongs to the family of trypsin-like serine proteases. The
expression of PKal is associated with multiple physiological systems or pathways such as …

Hereditary angioedema caused by C1-esterase inhibitor deficiency: a literature-based analysis and clinical commentary on prophylaxis treatment strategies

RG Gower, PJ Busse, E Aygören-Pürsün… - World Allergy …, 2011 - Springer
Hereditary angioedema (HAE) caused by C1-esterase inhibitor deficiency is an autosomal-
dominant disease resulting from a mutation in the C1-inhibitor gene. HAE is characterized …

Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activation

AC Clermont, N Murugesan, HJ Edwards… - Frontiers in …, 2023 - frontiersin.org
Background: The kallikrein kinin system (KKS) is an established pharmacological target for
the treatment and prevention of attacks in hereditary angioedema (HAE). Proteolytic …

Hereditary angioedema: a review of the current and evolving treatment landscape

SD Betschel, A Banerji, PJ Busse, DM Cohn… - The Journal of Allergy …, 2023 - Elsevier
Hereditary angioedema (HAE) is a rare disease characterized by sudden and often
unprovoked episodes of swelling that can be potentially life-threatening when it involves the …

[PDF][PDF] Overview of epidemiology, pathophysiology, and disease progression in hereditary angioedema

WR Lumry - Am J Manag Care, 2013 - ajmc.s3.amazonaws.com
Hereditary angioedema (HAE) is an autosomal dominant disease caused by a deficiency in
functional C1 inhibitor affecting an estimated 1 in 50,000 individuals in the United States …

Personalized medicine in allergy

M Ferrando, D Bagnasco, G Varricchi… - Allergy, asthma & …, 2017 - synapse.koreamed.org
Allergic disease is among the most common pathologies worldwide and its prevalence has
constantly increased up to the present days, even if according to the most recent data it …

Hereditary angioedema: a bradykinin-mediated swelling disorder

J Björkqvist, A Sala-Cunill… - Thrombosis and …, 2013 - thieme-connect.com
Edema is tissue swelling and is a common symptom in a variety of diseases. Edema form
due to accumulation of fluids, either through reduced drainage or increased vascular …

Before and after, the impact of available on-demand treatment for HAE.

SC Christiansen, A Bygum, A Banerji… - Allergy & Asthma …, 2015 - search.ebscohost.com
Availability of effective treatment for acute attacks is expected to transform the care of
hereditary angioedema (HAE) patients. We felt that it would be of interest to test these …

Elevated plasma levels of vascular permeability factors in C1 inhibitor‐deficient hereditary angioedema

S Loffredo, M Bova, C Suffritti, F Borriello, A Zanichelli… - Allergy, 2016 - Wiley Online Library
Background Hereditary angioedema with C1 inhibitor deficiency (C1‐INH‐HAE) is a rare
inherited genetic disease characterized by recurrent swelling episodes of the skin …